Video

ACC 2020: Results from the Global EXPAND Study

Published: 28 Apr 2020

  • Views:

    Views Icon 229
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

D Scott Lim (UVA Health System, Charlottesville, VA, US) discusses the most recent outcomes with MitraClip™ (NTR/XTR) System in primary mitral regurgitation.

Questions:

1. How prevalent is primary MR and what is the current guidance for Mitraclip™ use in these patients?
2. What are the objectives of EXPAND?
3. Can you describe the study design & inclusion criteria ?
4. Could you describe your key outcome and safety findings?
5. How were outcomes affected by anatomical complexity?
6. Were there differences in outcomes between the NTR/XTR devices?
7. What conclusions can be made and what are the implications on practice?
8. We have seen high-volume centres exhibit better outcomes with Mitraclip™, was this the case in EXPAND?
9. How should this research be expanded upon?

 

Interviewer: Victoria Perroud